2025
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Du Z, Pandey A, Moghadas S, Bai Y, Wang L, Matrajt L, Singer B, Galvani A. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nature Medicine 2025, 31: 647-652. PMID: 39789324, PMCID: PMC11835734, DOI: 10.1038/s41591-024-03431-7.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusSyncytial virusRSV diseaseImpact of vaccinationBurden of respiratory syncytial virusVaccination of pregnant womenRSV-related mortalityProtein-based vaccinesVaccination of older adultsRSV vaccinePregnant womenSeasonal influenzaVaccine uptake ratesInfant hospitalizationClinical trialsPrefusion FHospital costsInfantsHealth burdenAdult immunizationVaccineOlder adultsHospitalEnhanced uptakeHigh-income countries
2019
Ebola vaccination in the Democratic Republic of the Congo
Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. Ebola vaccination in the Democratic Republic of the Congo. Proceedings Of The National Academy Of Sciences Of The United States Of America 2019, 116: 10178-10183. PMID: 31036657, PMCID: PMC6525480, DOI: 10.1073/pnas.1817329116.Peer-Reviewed Original ResearchConceptsContacts of casesImpact of vaccinationFrontline healthcare workersEbola vaccinationEbola vaccineVaccination programHealthcare workersLong-range disseminationVaccination campaignCase confirmationEbola transmissionHigh-risk regionsEbola riskVaccinationFuture outbreaksRiskEarly implementationEbolaLevel of riskDemocratic RepublicGlobal spreadOutbreakVaccineInfectionDoses
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply